Over the previous 20 years we have seen a significant change in the healthcare industry. Small molecules have been pushed out of the blockbuster limelight by biologics. Decreasing sequencing cost has allowed more targeted R&D and the use of increasingly interdisciplinary data to influence prognosis has become standard practice. All of this points to a healthcare future with an increasingly personalized approach. But how will this future come together?
We are on the brink of a technological revolution in healthcare where data collected from all different sources will influence the way we view, prevent and cure disease. This approach aims to master the curative means of disease treatment and extend it’s branches into preventive and longevity based means. The constant monitoring from cradle to grave will give insights into how we should live our lives, how we should eat and even determine where we shall live.
The drastic shift in focus expected in the coming years leave many questions about current business models unanswered. Will the ‘old’ models of the small molecule giants suffice when used on biologics? How will precision medicine and patient stratification affect the pricing and affordability of treatment? How will data companies benefit from the pricing turmoil and how big a part will they play in the future of healthcare?
The questions are on the near horizon and we aim to address these in the Health Horizons conference 2019.
For more information please visit: https://www.horizons.health/